Search - tctmd.com

Displaying 661 - 680 of 681

Sort: Relevancy | Date

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

Caitlin E. Cox

April 20, 2011

News Industry News

St. Jude Medical Receives FDA Approval for New Bi-Directional Ablation Catheters

April 04, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Conference News

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Caitlin E. Cox

April 03, 2011

News Industry News

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

April 03, 2011

News Industry News

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

March 28, 2011

News Industry News

Medtronic Announces FDA Approval of Consulta® and Syncra™ Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems

March 24, 2011

News Industry News

Medtronic CareLink® Network Remote Monitoring Helps Improve Patient Care and Reduce Healthcare Costs

March 07, 2011

News Industry News

Medtronic Announces European Launch of Achieve™ Mapping Catheter

March 03, 2011

News Industry News

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

March 02, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

Jason Kahn

February 13, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Jason Kahn

January 23, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

News Industry News

Boston Scientific to Acquire Atritech

January 18, 2011

News Industry News

St. Jude Medical Announces Launch of the ViewMate Z Intracardiac Ultrasound System and ViewFlex Plus ICE Catheter

January 12, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

Caitlin E. Cox

January 11, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

January 04, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Advertisement

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

St. Jude Medical Receives FDA Approval for New Bi-Directional Ablation Catheters

PARTNER: TAVI Cost Effective Compared With Standard Care

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

Medtronic Announces FDA Approval of Consulta® and Syncra™ Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Systems

Medtronic CareLink® Network Remote Monitoring Helps Improve Patient Care and Reduce Healthcare Costs

Medtronic Announces European Launch of Achieve™ Mapping Catheter

Boston Scientific Strengthens Structural Heart Product Portfolio By Completing Acquisition of Atritech

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Boston Scientific to Acquire Atritech

St. Jude Medical Announces Launch of the ViewMate Z Intracardiac Ultrasound System and ViewFlex Plus ICE Catheter

NEJM Letters Take on PARTNER Trial

Bayer’s Rivaroxaban Submitted for Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation in the US

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content